News | May 21, 2009

LightLab Launches Nonocclusive HD OCT Intracoronary Imaging System

An example of an intravascular OCT image using the LightLab system.


May 21, 2009 - LightLab Imaging Inc. this week is launching its next generation optical coherence tomography (OCT) system, the C7XR FD-OCT Imaging System with the C7 Dragonfly Imaging Catheter, at EuroPCR 2009 in Barcelona, Spain.

The C7XR FD-OCT system is the world’s first approved frequency domain OCT product for intracoronary imaging, having received CE mark in March. The C7XR FD-OCT and C7 Dragonfly imaging catheter enables micron level resolution imaging of the coronary artery with the capability to scan a 40 mm artery segment in less than three seconds with a single nonocclusive catheter.

“The C7XR system and C7 Dragonfly imaging catheter represent a significant step forward for intracoronary imaging,” said Dr. Francesco Prati, Ospedale San Giovanni, Rome. “I am very pleased with the speed and simplicity of the imaging procedure and the improvements in image quality are truly impressive. I would expect frequency domain OCT to replace IVUS in many cases or centers.”

OCT generates intravascular images with a resolution up to 10 to 15 times greater than other clinically available imaging devices, including intravascular ultrasound (IVUS). With its higher resolution, OCT may reduce observer variability in all standard cross-sectional measurements.

The C7XR system follows the M2x OCT Imaging System, LightLab’s Time Domain OCT (TD-OCT) device, which is available in more than 20 countries worldwide. More than 10,000 patient intracoronary images have been taken since the company launched the M2x. Until the launch of the C7XR FD-OCT Imaging System the M2x was the only commercially available intracoronary OCT imaging device in the world. The C7XR system is 10 times faster and has a higher resolution. Unlike previous OCT systems, the new release can image vessels without the need for vessel occlusion, which was a big complaint and drawback of previous OCT systems.

For more information: www.lightlabimaging.com


Related Content

News | Intra-Vascular Ultrasound (IVUS)

Oct. 28, 2024 — Cardiawave SA, developer of Valvosoft Non-Invasive Ultrasound Therapy (NIUT) device for treating severe ...

Home November 07, 2024
Home
Sponsored Content | Webinar | Intra-Vascular Ultrasound (IVUS)

Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the ...

Home June 27, 2023
Home
News | Intra-Vascular Ultrasound (IVUS)

February 16, 2023 — Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters ...

Home February 16, 2023
Home
News | Intra-Vascular Ultrasound (IVUS)
Conavi Medical Inc., a leader of hybrid imaging guidance for common minimally invasive heart procedures, plans to expand ...
Home February 16, 2022
Home
News | Intra-Vascular Ultrasound (IVUS)

November 9 2021 — A new large-scale, real-world analysis of Centers for Medicare and Medicaid Services (CMS) outcomes ...

Home November 09, 2021
Home
Feature | Intra-Vascular Ultrasound (IVUS) | By Dave Fornell, DAIC Editor

Intravascular ultrasound (IVUS) is the workhorse intravascular imaging modality in cardiac cath labs. It is used to help ...

Home October 21, 2021
Home
News | Intra-Vascular Ultrasound (IVUS)

October 20, 2021 — Philips, a global leader in health technology and intravascular ultrasound (IVUS) solutions ...

Home October 20, 2021
Home
News | Intra-Vascular Ultrasound (IVUS)

October 2, 2019 — Philips Healthcare is utilizing Level Ex’s video game app design expertise to train interventional ...

Home October 02, 2019
Home
News | Intra-Vascular Ultrasound (IVUS)

October 2, 2018 — Intravascular ultrasound (IVUS) guidance improved clinical outcomes over angiography guidance during ...

Home October 02, 2018
Home
News | Intra-Vascular Ultrasound (IVUS)

July 12, 2018 — Intact Vascular Inc. announced the publication of the iDissection Classification trial results in the ...

Home July 12, 2018
Home
Subscribe Now